Fauci: Considerable Pharma Interest In Zika Vaccine
This article was originally published in Scrip
Executive Summary
Unlike what happened with the Ebola virus, Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID), said he doesn't foresee any trouble in getting biopharmaceutical partners on board to pursue a vaccine against the Zika virus, a mosquito-borne infection that has quickly spread throughout 22 countries in Central and South America and the Caribbean since this past May, when it was first detected in Brazil.